Resolution Therapeutics scores £63.5 million Series B
The UK cell therapy biotech will now advance its first candidate cell therapy to clinical trials for treatment of liver disease.
Archives for October 3, 2024
Chiesi Group launches biotechnology center in Italy, backed by a €400m investment
The newly opened Biotech Center of Excellence will be dedicated to developing and producing biological drugs, housing the entire supply chain.